The first long-term clinical study on 3D-printed bioceramic patient-specific implants (PSI) shows a total success rate of over 92% using Lithoz LithaBone TCP 300 tricalcium phosphate material.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback